Warning letter · FDA Warning Letters, Historical Archive

Nutritional Supplements Corporation Inc: FDA Warning Letter 608903 (Aug 25, 2020)

Agency action: Aug 25, 2020Record ID: fda_warning_-35cfbf4fae3c2cad
View official source ↗

What happened

Original notice title

Nutritional Supplements Corporation Inc MARCS-CMS 608903, August 25, 2020

From the archived source record

In addition, this patented formula can help support the effectiveness of the antiviral and other drugs while its immune boosting nutrients help protect naturally from the toxic effects of the antiviral medications. This nutritional support, when combined with standard HIV/AIDS drug treatment, can improve the quality of life and maximize opportunity to extend life expectancy.” “Viadevita is specially formulated to support the overall health and immune systems of individuals with HIV/AIDS … It can also support the effectiveness of antiviral drugs while simultaneously helping to protect naturally from the toxic effects of some medications.” On your Amazon product page for “Viadevita”: “WHAT IS HIV AND AIDS? A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, “Vitadone,” “Diabrex,” and “Viadevita” fail to bear adequate directions for their intended use and, therefore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]. The introduction or delivery for introduction into interstate commerce of these misbranded drugs violates section 301(a) of the Act [21 U.S.C. 331(a)]. The violations cited in this letter are not intended to be an all-inclusive list of violations that exist in connection with your products. You are responsible for investigating and determining the causes of the violations identified above and for preventing their recurrence or the occurrence of other violations. You should take prompt action to correct the violations cited in this letter. Failure to promptly correct these violations may result in legal action without further notice, including, without limitation, seizure and injunction. Within fifteen working days of receipt of this letter, please notify this office in writing of the specific steps that you have taken to correct violations.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Historical warning letter; closeout not established by annual index
Source checked
Jul 16, 2026
Record revision
0e30007eb127

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Diabrex; Viadevita; Vitadone
Company
Nutritional Supplements Corporation Inc
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.